These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19951629)

  • 1. Longitudinal melanonychia induced by capecitabine.
    Paravar T; Hymes SR
    Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onycholysis with the appearance of a "sunset" secondary to capecitabine.
    Maino KL; Norwood C; Stashower ME
    Cutis; 2003 Sep; 72(3):234-6. PubMed ID: 14533836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
    Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
    Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
    Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine induced inflammation of actinic keratoses.
    Krathen M; Treat J; James WD
    Dermatol Online J; 2007 Oct; 13(4):13. PubMed ID: 18319010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Capecitabine-induced hyperpigmentation].
    Vázquez-Bayo C; Rodríguez-Bujaldón AL; Jiménez-Puya R; Galán-Gutiérrez M; Moreno-Giménez JC
    Actas Dermosifiliogr; 2007 Sep; 98(7):491-3. PubMed ID: 17669305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
    Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
    [No Abstract]   [Full Text] [Related]  

  • 8. Capecitabine induced cutaneous hyperpigmentation: report of a case.
    Pui JC; Meehan S; Moskovits T
    J Drugs Dermatol; 2002 Sep; 1(2):202-5. PubMed ID: 12847748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine induced cardiotoxicity: a case report and review of literature.
    Tunio MA; Hashmi A; Shoaib M
    Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N; Misra V
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract]   [Full Text] [Related]  

  • 11. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
    Do JE; Kim YC
    Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
    Tavares-Bello R
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
    [No Abstract]   [Full Text] [Related]  

  • 13. Nail and periungual toxicity following capecitabine therapy.
    Vaccaro M; Barbuzza O; Guarneri F; Guarneri B
    Br J Clin Pharmacol; 2008 Aug; 66(2):325-6. PubMed ID: 18384441
    [No Abstract]   [Full Text] [Related]  

  • 14. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 15. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 16. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
    Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
    J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
    [No Abstract]   [Full Text] [Related]  

  • 17. Onycholysis associated with capecitabine in patients with breast cancer.
    Hogeling M; Howard J; Kanigsberg N; Finkelstein H
    J Cutan Med Surg; 2008; 12(2):93-5. PubMed ID: 18346407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
    Serrão VV; Feio AB
    Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
    [No Abstract]   [Full Text] [Related]  

  • 19. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine].
    Tejera A; Bosch RJ; López N; Herrera E
    Actas Dermosifiliogr; 2006 Oct; 97(8):536-8. PubMed ID: 17067535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.